Rhein inhibits invasion and migration of human nasopharyngeal carcinoma cells in vitro by down-regulation of matrix metalloproteinases-9 and vascular endothelial growth factor

Oral Oncology

Volumn 45, Issue 6, 2009, Pages 531-537

  Lin, Meng Liang ^a,c   Chung, Jing Gung ^a   Lu, Yao Cheng ^b   Yang, Chiou Ying ^c   Chen, Shih Shun ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

GRB2 SOS Ras MAPK; MMP 9; Nasopharyngeal carcinoma cells; NF B; Rhein; VEGF

Indexed keywords

GELATINASE B; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RHEIN; VASCULOTROPIN;

ARTICLE; CANCER INVASION; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; ONCOGENE RAS; PRIORITY JOURNAL;

ANTHRAQUINONES; CELL MOVEMENT; DOWN-REGULATION; ENZYME INHIBITORS; GRB2 ADAPTOR PROTEIN; HUMANS; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NF-KAPPA B; RAS PROTEINS; SON OF SEVENLESS PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67349249141     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.07.012     Document Type: Article

References (44)

1. Lin T., Hsu M., Chen K., Chiang T., Jung P., and Hirayama T. Morbidity and mortality of cancer of the nasopharynx in Taiwan. Gann Monogr 10 (1971) 137-144
2. International Agency for Research on Cancer, International Association of Cancer Registries. Cancer incidence in five continents. Geneva: World Health Organization; 1976.
3. Sham J.S., Choy D., and Choi P.H. Nasopharyngeal carcinoma: the significance of neck node involvement in relation to the pattern of distant failure. Br J Radiol 63 746 (1990) 108-113
4. Curran S., and Murray G.I. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36 13 Spec No (2000) 1621-1630
5. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13 8 (1999) 781-792
6. Watanabe H., Nakanishi I., Yamashita K., Hayakawa T., and Okada Y. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci 104 Pt 4 (1993) 991-999
7. Itoh T., Tanioka M., Matsuda H., Nishimoto H., Yoshioka T., Suzuki R., et al. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17 2 (1999) 177-181
8. Lauricella-Lefebvre M.A., Castronovo V., Sato H., Seiki M., French D.L., and Merville M.P. Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells. Invas Metast 13 6 (1993) 289-300
9. Sato H., and Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8 2 (1993) 395-405
10. Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 6 3 (2004) 203-208
11. Orlowski R.Z., and Baldwin Jr. A.S. NF-kappaB as a therapeutic target in cancer. Trends Mol Med 8 8 (2002) 385-389
12. Miccadei S., Pulselli R., and Floridi A. Effect of lonidamine and rhein on the phosphorylation potential generated by respiring rat liver mitochondria. Anticancer Res 13 5A (1993) 1507-1510
13. Raimondi F., Santoro P., Maiuri L., Londei M., Annunziata S., Ciccimarra F., et al. Reactive nitrogen species modulate the effects of rhein, an active component of senna laxatives, on human epithelium in vitro. J Pediatr Gastroenterol Nutr 34 5 (2002) 529-534
14. Lin S., Fujii M., and Hou D.X. Rhein induces apoptosis in HL-60 cells via reactive oxygen species-independent mitochondrial death pathway. Arch Biochem Biophys 418 2 (2003) 99-107
15. +2 on rhein-induced apoptosis in human cervical cancer Ca Ski cells. Anticancer Res 27 1A (2007) 379-389
16. 2+dependent mitochondrial death pathway in human nasopharyngeal carcinoma cells. Anticancer Res 27 5A (2007) 3313-3322
17. Huang Y.T., Hwang J.J., Lee L.T., Liebow C., Lee P.P., Ke F.C., et al. Inhibitory effects of a luteinizing hormone-releasing hormone agonist on basal and epidermal growth factor-induced cell proliferation and metastasis-associated properties in human epidermoid carcinoma A431 cells. Int J Cancer 99 4 (2002) 505-513
18. Heo J.C., Park J.Y., Woo S.U., Rho J.R., Lee H.J., Kim S.U., et al. Dykellic acid inhibits cell migration and tube formation by RhoA-GTP expression. Biol Pharm Bull 29 11 (2006) 2256-2259
19. Park H.J., Chung H.J., Min H.Y., Park E.J., Hong J.Y., Kim W.B., et al. Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases. Biochem Pharmacol 71 1-2 (2005) 21-31
20. Wang Z., Banerjee S., Li Y., Rahman K.M., Zhang Y., and Sarkar F.H. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res 66 5 (2006) 2778-2784
21. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2 10 (2002) 795-803
22. Schlaepfer D.D., Jones K.C., and Hunter T. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events. Mol Cell Biol 18 5 (1998) 2571-2585
23. Atabey N., Gao Y., Yao Z.J., Breckenridge D., Soon L., Soriano J.V., et al. Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions. J Biol Chem 276 17 (2001) 14308-14314
24. Saucier C., Papavasiliou V., Palazzo A., Naujokas M.A., Kremer R., and Park M. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis. Oncogene 21 12 (2002) 1800-1811
25. Nakajima M., Welch D.R., Belloni P.N., and Nicolson G.L. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 47 18 (1987) 4869-4876
26. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 6573 (1996) 439-442
27. Wizigmann-Voos S., Breier G., Risau W., and Plate K.H. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55 6 (1995) 1358-1364
28. Eriksson A., Cao R., Pawliuk R., Berg S.M., Tsang M., Zhou D., et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell 1 1 (2002) 99-108
29. Ferrara N., and Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5 12 (1999) 1359-1364
30. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362 6423 (1993) 841-844
31. Buday L. Membrane-targeting of signalling molecules by SH2/SH3 domain-containing adaptor proteins. Biochim Biophys Acta 1422 2 (1999) 187-204
32. Okutani T., Okabayashi Y., Kido Y., Sugimoto Y., Sakaguchi K., Matuoka K., et al. Grb2/Ash binds directly to tyrosines 1068 and 1086 and indirectly to tyrosine 1148 of activated human epidermal growth factor receptors in intact cells. J Biol Chem 269 49 (1994) 31310-31314
33. Pelicci G., Lanfrancone L., Grignani F., McGlade J., Cavallo F., Forni G., et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70 1 (1992) 93-104
34. Saucier C., Khoury H., Lai K.M., Peschard P., Dankort D., Naujokas M.A., et al. The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis. Proc Natl Acad Sci USA 101 8 (2004) 2345-2350
35. Boerner J.L., Danielsen A.J., Lovejoy C.A., Wang Z., Juneja S.C., Faupel-Badger J.M., et al. Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis. Oncogene 22 43 (2003) 6679-6689
36. Kroll J., and Waltenberger J. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem 272 51 (1997) 32521-32527
37. Zhang W., Trible R.P., Zhu M., Liu S.K., McGlade C.J., and Samelson L.E. Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T cell antigen receptor-mediated signaling. J Biol Chem 275 30 (2000) 23355-23361
38. Carlier M.F., Nioche P., Broutin-L'Hermite I., Boujemaa R., Le Clainche C., Egile C., et al. GRB2 links signaling to actin assembly by enhancing interaction of neural Wiskott-Aldrich syndrome protein (N-WASp) with actin-related protein (ARP2/3) complex. J Biol Chem 275 29 (2000) 21946-21952
39. Reddy K.B., Krueger J.S., Kondapaka S.B., and Diglio C.A. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int J Cancer 82 2 (1999) 268-273
40. Zeigler M.E., Chi Y., Schmidt T., and Varani J. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J Cell Physiol 180 2 (1999) 271-284
41. Maina F., Casagranda F., Audero E., Simeone A., Comoglio P.M., Klein R., et al. Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development. Cell 87 3 (1996) 531-542
42. Lim E.J., Lee S.H., Lee J.G., Kim J.R., Yun S.S., Baek S.H., et al. Toll-like receptor 9 dependent activation of MAPK and NF-kB is required for the CpG ODN-induced matrix metalloproteinase-9 expression. Exp Mol Med 39 2 (2007) 239-245
43. Rodrigues G.A., Park M., and Schlessinger J. Activation of the JNK pathway is essential for transformation by the Met oncogene. EMBO J 16 10 (1997) 2634-2645
44. Gong Q., Cheng A.M., Akk A.M., Alberola-Ila J., Gong G., Pawson T., et al. Disruption of T cell signaling networks and development by Grb2 haploid insufficiency. Nat Immunol 2 1 (2001) 29-36